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Objective: College students with attention deficit/hyperactivity disorder (ADHD) are at increased 
risk for numerous educational and psychosocial difficulties. This study reports findings from a 
large, multisite randomized controlled trial examining the efficacy of a treatment for this 
population, known as ACCESS—Accessing Campus Connections and Empowering Student 
Success. Method: ACCESS is a cognitive–behavioral therapy program delivered via group 
treatment and individual mentoring across two semesters. A total of 250 students (18–30 years of 
age, 66% female, 6.8% Latino, 66.3% Caucasian) with rigorously defined ADHD and 
comorbidity status were recruited from two public universities and randomly assigned to receive 
ACCESS immediately or on a 1-year delayed basis. Treatment response was assessed on three 
occasions, addressing primary (i.e., ADHD, executive functioning, depression, anxiety) and 
secondary (i.e., clinical change mechanisms, service utilization) outcomes. Results: Latent 
growth curve modeling (LGCM) revealed significantly greater improvements among immediate 
ACCESS participants in terms of ADHD symptoms, executive functioning, clinical change 
mechanisms, and use of disability accommodations, representing medium to large effects 
(Cohen’s d, .39–1.21). Across these same outcomes, clinical significance analyses using reliable 
change indices (RCI; Jacobson & Truax, 1992) revealed significantly higher percentages of 
ACCESS participants showing improvement. Although treatment-induced improvements in 
depression and anxiety were not evident from LGCM, RCI analyses indicated that immediate 
ACCESS participants were less likely to report a worsening in depression/anxiety symptoms. 
Conclusions: Findings from this RCT provide strong evidence in support of the efficacy and 
feasibility of ACCESS as a treatment for young adults with ADHD attending college. 
 




Attention Deficit/Hyperactivity Disorder (ADHD; American Psychiatric Association, 2013) is 
characterized by developmentally inappropriate symptoms of inattention and/or hyperactivity-
impulsivity that remain present and impair functioning across the life span. Although much has 
been learned about the impact of ADHD on children and adults (Barkley, 2015), relatively less 
research attention has been directed to the way in which ADHD unfolds among individuals 
transitioning through the developmental period known as emerging adulthood, from 18 to 25 
years of age (Arnett, 2007). Most of what is known about this segment of the ADHD population 
comes from studies of young adults attending 4-year colleges, which in recent years have 
witnessed dramatic increases in their enrollments of students with ADHD (Eagan et al., 
2014; Weyandt & DuPaul, 2012). For those individuals with ADHD who achieved a level of 
success during high school that made postsecondary admission possible, it would seem 
reasonable to expect that they might be able to continue displaying educational success during 
college. Contrary to this expectation, once enrolled in college, students with ADHD display 
significant academic deficits, including lower end-of-semester grade point averages (GPAs) and 
less effective study strategies, relative to their non-ADHD peers (DuPaul et al., 2018; Gormley et 
al., 2019). Although the directionality of the association is unclear, up to 55% of the ADHD 
college student population may also display comorbid psychiatric disorders, most often involving 
active depressive (32.3%) or anxiety (28.6%) disorders (Anastopoulos et al., 2018). Additional 
impairment has been reported in terms of poorer adjustment to college (Blasé et al., 2009) and an 
overall lower quality of life (Pinho et al., 2019). Together, such findings may help to explain 
why college students with ADHD are more likely to be placed on academic probation, to take 
longer to complete their degrees, and to drop out of college (Barkley et al., 2008; DuPaul et al., 
2018; Hechtman, 2017). 
 
Conceptually, it has been suggested that such difficulties are set in motion by a “perfect storm” 
of life circumstances that converge following the transition from high school into college 
(Anastopoulos & King, 2015). Upon enrolling in college, all students face increased demands for 
self-regulation, not only with respect to educational matters but also in terms of various personal 
and social responsibilities. This developmental transition is normative and often the reason why 
many first-year students, whether they have ADHD or not, experience trouble adjusting to 
college. For students with ADHD, navigating this developmental transition is substantially more 
challenging, in large part due to their lack of age-appropriate self-regulation abilities (Barkley, 
2015; Fleming & McMahon, 2012). Further complicating matters is the fact that many external 
supports that were in place prior to college, such as parental monitoring and school-based 504 
accommodations, are no longer available (Meaux et al., 2009). 
 
To reduce risk for negative outcomes, it is critically important for college students with ADHD 
to have ready access to treatment. On many college campuses, disability service 
accommodations are the primary mechanism by which students with ADHD receive assistance 
(Wolf et al., 2009). Unfortunately, many college students choose not to use such services 
(Fleming & McMahon, 2012). Moreover, when used alone, disability accommodations appear to 
produce minimal long-term benefits (e.g., Lewandowski et al., 2013; Miller et al., 2015) and do 
not directly address co-occurring executive functioning deficits (Antshel et al., 2014) and 
psychiatric disorders (Anastopoulos et al., 2018). Stimulant medication is another treatment 
option that has been well established in children and adults (Barkley, 2015), but research 
addressing its use with college students has been limited to only one clinical trial (DuPaul et al., 
2012). Despite this study’s promising results, showing that lisdexamfetamine dimesylate reduced 
ADHD symptoms and improved executive functioning, additional medication trials are needed to 
evaluate efficacy in conjunction with safety concerns, including the risk for misuse, abuse, and 
diversion on college campuses (Rabiner et al., 2009). 
 
More recently, psychosocial interventions for college students with ADHD have been developed 
and pilot tested (He & Antshel, 2017). These investigations incorporate a diverse array of 
therapeutic perspectives, including cognitive–behavioral therapy (CBT; LaCount et al., 
2015; Van der Oord et al., 2020), coaching (Prevatt & Yelland, 2015), dialectical behavior 
therapy (Fleming et al., 2015), mindfulness-based cognitive therapy (Gu et al., 2018), self-
monitoring (Scheithauer & Kelley, 2017), and organization, time management, and planning 
skills training (OTMP; LaCount et al., 2018). 
 
Findings from these initial investigations have consistently revealed significant improvements in 
primary ADHD symptoms, most often involving inattention (Fleming et al., 2015; Gu et al., 
2018; LaCount et al., 2015; LaCount et al., 2018,). Less often, improvements in self-reported 
executive functioning (Fleming et al., 2015) and symptoms of depression and anxiety (Gu et al., 
2018) have been observed. Although not routinely assessed, improvements in educational 
functioning have been reported, including decreases in self-reported academic impairment 
(LaCount et al., 2018), gains in self-reported learning strategies (LaCount et al., 2015; Prevatt & 
Yelland, 2015) and increased use of disability services and other campus resources 
(Anastopoulos & King, 2015). Notably, corresponding improvements in GPA have not been 
reliably demonstrated (Fleming et al., 2015; Gu et al., 2018; LaCount et al., 2018). 
 
Taken together, results from this emerging literature offer much promise for the role that 
psychosocial interventions, especially CBT programs, may play in the overall clinical 
management of college students with ADHD. At the same time, it is necessary to acknowledge 
that reported findings have been inconsistent across investigations, which limits conclusions 
about efficacy. Given that programmatic research in this area has been lacking, many of these 
inconsistent findings are likely attributable to methodological limitations and differences across 
studies (He & Antshel, 2017). These limitations include, for example, the use of small samples 
(n < 60) drawn from single-site university settings. Diagnostic rigor has typically been lacking, 
with many studies relying upon either symptom counts from a single rating scale or self-report of 
prior ADHD diagnoses as the basis for determining participants’ ADHD status. Although co-
occurring psychiatric conditions are common among individuals with ADHD, their presence has 
either not been addressed or addressed on a very limited basis. Additional cross-study differences 
are evident with respect to the format (i.e., group vs. individual) and number (i.e., 3–10) of 
treatment sessions offered, as well as the duration of treatment (i.e., 1–3 months). Furthermore, 
measures assessing clinical change mechanisms are rarely included; thus, the conceptual 
underpinnings of these interventions are not well understood. Also limited is our understanding 
of the persistence of therapeutic improvements beyond active treatment, with only a few studies 
reporting follow-up assessments of relatively short duration (i.e., 3 months). 
 
The present study reports findings from a large-scale, multisite randomized controlled trial 
(RCT) examining the efficacy of the CBT program known as ACCESS—Accessing Campus 
Connections and Empowering Student Success (Anastopoulos & King, 2015; Anastopoulos et 
al., 2020). ACCESS incorporates elements of empirically supported adult CBT programs (Safren 
et al., 2005; Solanto, 2011), adapted to the developmental needs of emerging adults with ADHD 
in college. ACCESS was originally developed, refined, and pilot tested in an open clinical trial 
involving 88 college students with rigorously defined ADHD (Anastopoulos & King, 2015). An 
iterative process was used to determine optimal mode of delivery (e.g., number and length of 
treatment sessions). In its current and final form, ACCESS is delivered across two consecutive 
semesters, the first of which is an intensive 8-week active phase, followed by a less intensive 
semester-long maintenance phase in which treatment is gradually faded. In each phase, treatment 
is delivered in both a group and individual mentoring format. The active phase includes eight 
weekly group sessions, each of which is 90 min in length. Concurrent with these group sessions 
are weekly individual mentoring sessions, each of which is approximately 30 min in length. The 
purpose of individual mentoring is threefold: to reinforce what the student learns in the CBT 
group; to assist the student in establishing personal goals and monitoring progress; and to help 
the student make connections with campus resources as needed (e.g., accommodations, 
counseling, medication). As part of the process of fading treatment during the maintenance 
phase, one 90-min booster group session is offered at the start of the semester, along with up to 
six 30-min individual mentoring sessions that can be scheduled flexibly throughout the semester 
at times best meeting participant needs. 
 
Both treatment delivery formats are used to address the goal of the ACCESS program—namely, 
to give college students with ADHD the knowledge and skills necessary to be successful in their 
daily life functioning. Specifically, ACCESS is designed to: (a) give college students a 
developmentally appropriate understanding of their own ADHD via a more intensive “dosage” of 
ADHD knowledge than is delivered in adult CBT programs (Safren et al., 2005; Solanto, 2011); 
(b) improve organization, time management, and other behavioral strategies that target executive 
functioning deficits commonly found among individuals with ADHD; and (c) increase adaptive 
thinking skills via cognitive therapy strategies to address co-occurring depression and anxiety 
features that are frequently comorbid with ADHD (Anastopoulos et al., 2018). In contrast with 
the sequential way in which adult CBT programs (Safren et al., 2005) deliver these treatment 
modules (i.e., ADHD knowledge → behavioral strategies → cognitive therapy), ACCESS 
delivers them simultaneously in an integrated fashion, focused on a common theme (e.g., 
academic functioning), in each of the eight active phase group sessions (see Figure 1). The 
underlying premise of ACCESS is that improvement in ADHD knowledge, behavioral strategies, 
and adaptive thinking skills—that is, the hypothesized clinical change mechanisms—will 
facilitate improvements in multiple domains of daily life functioning negatively impacted by 
ADHD. 
 
Results from our completed open clinical trial revealed statistically significant improvements in 
ADHD symptoms, executive functioning, levels of depression and anxiety, and the number of 
semester credit hours attempted and earned (Anastopoulos et al., 2020). Of note, such 
improvements were evident at the end of the active phase and maintained throughout the 
maintenance phase, 5 to 7 months after treatment started. 
 
The current study builds upon these promising findings and addresses many of the previously 
mentioned limitations in the literature. For example, the current RCT used a large sample of 250 
college students with rigorously defined ADHD and comorbid psychiatric diagnoses drawn from 
two university settings. Participants were randomly assigned either to a group receiving the 
ACCESS treatment immediately or to a Delayed Treatment Control (DTC) condition receiving 
treatment 1 year later. In contrast with other CBT programs, ACCESS incorporates concurrent 
delivery of group and individual sessions, which affords participants exposure not only to the 
unique benefits of each treatment modality, but also to a greater total number of therapeutic 
contacts (i.e., 21–25), thereby increasing the intensity of treatment. To better address the chronic 
nature of ADHD, participants remain in contact with ACCESS staff for a substantially longer 
duration (i.e., 6–7 months across two semesters) than is offered in similar interventions. To 
assess the stability of therapeutic change, outcome was assessed on three occasions, spanning a 
full academic year. Also included were measures of hypothesized clinical change mechanisms 
that have direct bearing on the construct validity of the design. 
 
 
Figure 1. Weekly CBT Group Session Content During the Active Phase of the ACCESS 
Intervention. 
Note. CBT = cognitive–behavioral therapy; ADHD = attention deficit/hyperactivity disorder. 
 
The purpose of this article is to present RCT findings that directly address the efficacy of 
ACCESS across its entire two-semester long delivery. Given the large number of outcome 
variables included in the RCT, the focus of this initial efficacy article is limited to treatment-
induced changes in: (a) primary outcomes addressing ADHD symptoms, executive functioning 
(EF), and co-occurring symptoms of depression and anxiety, and (b) secondary outcomes related 
to hypothesized clinical change mechanisms and treatment service utilization. It was 
hypothesized that, relative to the DTC condition, participants receiving ACCESS would display 
significantly greater improvements in their ADHD symptoms, EF, co-occurring depression and 
anxiety symptoms, hypothesized clinical change mechanisms, and treatment service utilization 
after both phases (i.e., active and maintenance) of treatment were completed. Using reliable 
change indices (Jacobson & Truax, 1992) to address the clinical significance of these findings, it 
was also expected that higher percentages of ACCESS participants would show reliable 






Participants for this study were recruited from two large, public universities in the southeastern 
United States that serve large numbers of first-generation college students and students of color. 
As shown in Figure 2, a total of 361 students were initially consented into the project and 
screened for eligibility. Eighty-one were deemed ineligible, either because they did not meet 
research criteria for ADHD or because they displayed a co-occurring psychiatric condition (e.g., 
autism spectrum disorder, bipolar disorder, obsessive–compulsive disorder) requiring treatment 
that went beyond the scope of the intervention. The remaining 280 participants meeting 
eligibility criteria were randomly assigned to receive ACCESS immediately or on a 1-year 
delayed basis in the DTC group. Random assignment was stratified by medication status to 
ensure that equivalent numbers of participants taking ADHD medication were assigned to each 
group condition. Thirty eligible students assigned to the immediate ACCESS group could not 
begin treatment due to class and job schedules that conflicted with planned group meeting times. 
This resulted in a final sample of 250 participants, including 165 females (66%) and 85 males 
(34%), ranging in age from 18 to 30 years (M = 19.7, 8.4% ≥ 23) and representing a cross-
section of postsecondary education levels (i.e., 47.6% first-year students, 16.4% sophomores, 
26.4% juniors, 9.6% seniors). A significant number of these students had experienced academic 
difficulties prior to enrolling in college, with 26.8% having received at least one D or F grade in 
high school. Another 38.4% reported having to work part-time to support themselves financially 
while attending college. Approximately 6.8% of the participants reported having Hispanic/Latino 
backgrounds; 66.3% identified as Caucasian, 14.2% as African American, 5.3% as Asian, 10.6% 
as multiracial, and 3.3% as other or not reported. 
 
A multigating, multimethod, multi-informant assessment approach (Ramsay, 2015) was used to 
determine ADHD and comorbidity status. Potential participants were initially screened based on 
their responses to the ADHD Rating Scale-5 (DuPaul et al., 2016). Students endorsing four or 
more symptoms of either inattention and/or hyperactivity-impulsivity were scheduled for further 
evaluation, which included: a semistructured interview assessing current ADHD symptoms and 
their associated impairment; self-report rating scales assessing current and childhood symptoms 
of ADHD; a structured interview addressing other psychiatric disorders that may be exclusionary 
or co-occurring with ADHD; and self-report ratings of depression and anxiety symptoms. 
Family, school, and social background information was also collected, along with prior mental 
health evaluation and treatment histories. To increase the accuracy of addressing the childhood 
onset criteria, efforts were made (with consent) to obtain parental ratings of participants’ ADHD 
symptoms occurring prior to 12 years of age. For a variety of reasons (e.g., consent withheld, 
parents not available), it was not possible to obtain parental ratings for 12.4% of the sample, but 
this did not preclude participation in the study. All collected evaluation data were forwarded to a 
panel of three ADHD experts (i.e., the two study principal investigators and a nationally 
recognized adult ADHD clinical consultant), who independently reviewed each case to 
determine if criteria for ADHD and/or other psychiatric disorders had been met, as defined in 
the Diagnostic and Statistical Manual of Mental Disorders–Fifth Edition (DSM–5; American 
Psychiatric Association, 2013). Final determination of ADHD and psychiatric comorbidity status 
required unanimous panel agreement. 
 
 
Figure 2. Consort Diagram Showing Flow of Participants Through Clinical Trial. Drop-Out 
Rates Were Comparable for the Immediate (20.2%) and Delayed Treatment Groups (22.1%) at 
Posttreatment (Postmaintenance Phase). Drop-Outs Did Not Differ From Completers on Any 
Pretreatment Demographic, Primary Outcome, or Secondary Outcome 
 
Included among the 250 participants in the final sample were 58.4% who received an ADHD 
Combined presentation diagnosis and 41.6% who displayed an ADHD Predominantly Inattentive 
presentation. Although it was not a requirement for inclusion in the study, 66.4% of these 
participants reported having been previously diagnosed with ADHD; another 24.4% reported 
histories of being strongly suspected of having ADHD—that is, significant others (e.g., parents, 
teachers, friends) repeatedly raising the possibility that the participant might have ADHD. Sixty 
percent also met DSM–5 criteria for at least one psychiatric diagnosis co-occurring with ADHD, 
most often involving a current anxiety or depressive disorder. For clinical and ethical reasons, 
students in both conditions could participate in the study regardless of whether they were 
receiving other forms of treatment. At the time they were randomly assigned to a group, nearly 
half (47.2%) of the participants in the final sample were taking medication for ADHD; 27.7% 
were taking medication for other medical and mental health conditions, including 10.8% for the 
treatment of depression and anxiety. 
 
As shown in Table 1, the two groups (immediate = 119, DTC = 131) were statistically equivalent 
at pretreatment across these demographic and clinical variables of interest. 
 
Table 1. Pretreatment Demographic and Clinical Characteristics by Group 
 ACCESS DTC 
Variable M (SD) M (SD) 
Age (years) 19.7 (2.2) 19.6 (2.1) 
CAARS Total ADHD score 34.4 (9.2) 34.7 (8.9) 
 % % 
Sex (female) 64.7 67.2 
Race: Caucasian 66.1 66.4 
African-American 11.9 16.4 
Asian 5.1 5.5 
More than one race 11.9 9.4 
Other/not reported 5.1 2.4 
Ethnicity: Hispanic 7.0 6.6 
First year students 49.6 45.8 
Comorbidity status 62.2 58.0 
ADHD: Combined 58.8 58.0 
Predominantly inattentive 41.2 42.0 
ADHD medications 53.3 41.7 
Other medications 26.1 29.1 
Note. ACCESS = immediate treatment; DTC = Delayed Treatment Control; ADHD = attention deficit/hyperactivity 
disorder; CAARS = Conners Adult ADHD Rating Scale; Comorbidity status = presence of any non-ADHD 
psychiatric disorder; ADHD medication status = reported use of medication to treat ADHD; Other medication status 




Semi-Structured Interview for Adult ADHD 
 
The Semi-Structured Interview for Adult ADHD was developed specifically for this study 
because it allowed for a more thorough and simultaneous assessment of symptoms and ADHD-
specific impairment. For each of the 18 ADHD symptoms, respondents rated not only the 
frequency of occurrence but also the degree to which there was associated impairment in daily 
functioning. In contrast with the fixed way in which ADHD symptoms are listed in rating scales, 
interviewers were allowed to give developmentally appropriate parenthetical descriptions of 
ADHD symptoms to increase participant understanding of the questions being asked. Additional 
questioning is directed to the other DSM–5 criteria addressing duration, age of onset, and 
exclusionary conditions. Preliminary (unpublished) analyses indicate that this interview 
possesses satisfactory reliability (coefficient α from .84 to .90) and is highly correlated with 
CAARS-S:L symptom dimensions (from .78 to .84). Information from this interview was used in 
combination with other assessment data to determine ADHD status. 
 
ADHD Rating Scale-5 
 
The ADHD Rating Scale-5 (ARS-5; DuPaul et al., 2016) is an 18-item questionnaire that 
possesses excellent reliability (coefficient α from .89 to .94) and validity and has been used 
widely in research and practice. The self-report and parent-report versions of the ARS-5, which 
address current functioning, were modified to include a second column for rating each symptom 
during childhood. Together, these self-report and parent ratings were used to provide a more 
specific estimation of the onset and persistence of ADHD across the life span. 
 
Structured Clinical Interview for DSM–5: Research Version (SCID-5-RV) 
 
The SCID-5-RV (First, Williams, Karg, & Spitzer, 2015) screeners for the mood, anxiety, 
trauma, and substance use modules (coefficient α from .85 to .98) were initially administered to 
all participants, after which complete modules were given as needed for disorders suspected of 
being present. Information gathered from the SCID-5-RV was used to identify psychiatric 
conditions that could either rule out an ADHD diagnosis or co-occur with ADHD, as determined 
by the expert panel. 
 
Primary Outcome Measures 
 
Conners Adult ADHD Rating Scale, Self-Report, Long Version (CAARS-S:L) 
 
The CAARS-S:L (Conners et al., 2006) is a widely used, psychometrically sound (coefficient α 
from .73 to .84) measure of ADHD in adults. The DSM–IV Inattentive (IN), Hyperactive-
Impulsive (HI), and Total scores were used to assess treatment-related changes in ADHD 
symptoms. 
 
Behavior Rating Inventory of Executive Function–Adult Version (BRIEF-A) 
 
The BRIEF-A (Roth et al., 2005) is a 75-item psychometrically sound (coefficient α = .96) self-
report measure that generates nine clinical scales (e.g., Self-Monitoring, Planning, Working 
Memory, Emotional Control), as well as three composite scales—the Behavior Regulation Index 
(BRI), Metacognition Index (MCI), and overall Global Executive Composite (GEC)—which 
were used to assess executive functioning (EF) deficits. Higher scores on these BRIEF-A 
composite scales indicate poorer EF. 
 
Beck Depression Inventory, Second Edition (BDI-II) 
 
The BDI-II (Beck et al., 1996) is a psychometrically sound (coefficient α = .93) measure of adult 
depression that is widely used in research and clinical practice. The BDI-II total score served as a 
measure of treatment-induced changes in depressed mood. 
 
Beck Anxiety Inventory (BAI) 
 
The BAI (Beck & Steer, 1993) is a psychometrically sound (coefficient α = .92) measure of 
anxiety symptoms in adults, used widely in research and clinical practice. The BAI total score 
was used to assess changes in overall levels of anxiety. 
 
Secondary Outcome Measures 
 
Because we were not aware of existing measures for evaluating hypothesized clinical change 
mechanisms and participant service utilization, we assessed these constructs using procedures 
that we developed for this and related studies involving college students with ADHD. 
 
Test of ADHD Knowledge (TOAK) 
 
The TOAK is a 40-item questionnaire that measures general knowledge of ADHD. For each 
item, participants respond to statements about ADHD (e.g., “Hereditary factors play a major role 
in determining if someone will develop ADHD”) with “agree,” “disagree,” or “not sure.” 
Correctly endorsed “agree” and “disagree” items are summed to yield a total score, with higher 
scores indicating greater knowledge of ADHD. Preliminary (unpublished) findings based on the 
current sample indicate that the TOAK possesses excellent internal consistency (coefficient α = 
.86) and demonstrates evidence of convergent validity. 
 
Strategies for Success (SFS) 
 
The SFS contains 18 items that assess self-reported use of behavioral strategies (e.g., “Doing the 
most important tasks first”) for managing academic work in college. Respondents indicate how 
adeptly they use these strategies on a 5-point scale, with 1 indicating not well and 5 indicating 
very well. Items are summed to yield a total score, with higher scores indicating more frequent 
behavioral strategy use. Initial (unpublished) findings from the current sample suggest that the 
SFS possesses excellent internal consistency (coefficient α = .84). 
 
ADHD Cognitions Scale–College Version (ACS-CV) 
 
The ACS-CV is a 12-item questionnaire that assesses self-reported frequency of ADHD-related 
cognitions (e.g., “My work is better if I wait until the last minute”). Each item is rated on a 5-
point scale, and ratings for all 12 items are summed to create a total ACS-CV score, with higher 
scores reflecting more frequent engagement in maladaptive thinking patterns. The ACS-CV uses 
many of the same items found in the 7-item ACS developed for older adult populations (Knouse 
et al., 2019). For college students, a psychometrically sound 12-item version was found to be 
more appropriate, with satisfactory internal consistency (coefficient α = .77) and evidence of 
convergent and divergent validity. 
 
Services for College Students Questionnaire (SCSQ) 
 
The SCSQ is a self-report descriptive measure that monitors participant use of campus support 
services (e.g., disability accommodations) and other treatments (e.g., ADHD medication). For 
each service, participants first indicate whether they receive this service and then provide 
information about its frequency, duration, and effectiveness. In this study, participant use of 
disability accommodations, ADHD medication, medication for other medical/mental health 




Students were recruited from multiple sources, including various campus support units (e.g., 
disability services, student health services, first-year summer orientation sessions, and campus 
fliers). All potential participants were made aware that this was a clinical trial for individuals 
with ADHD, and that ADHD status would be evaluated and confirmed prior to entry into the 
trial. Interested students contacted the project coordinators at each site and were initially 
screened for study eligibility by phone. Potentially eligible participants subsequently underwent 
a more comprehensive evaluation, during which information pertinent to determining eligibility 
for the study, as well as pretreatment outcome data, were collected. 
 
Recruitment was ongoing, and ACCESS was delivered to five successive cohorts of participants 
across consecutive semesters from the fall of 2015 through the spring of 2018. Fall cohorts ran 
from early September through mid-November; spring cohorts from early February into mid-
April. Treatment outcome data were collected from both groups on three occasions: within 2 
weeks prior to beginning active treatment, immediately after active treatment, and in the final 2–
3 weeks of the maintenance phase semester. While waiting to participate in ACCESS on a 1-year 
delayed basis, DTC participants were permitted to receive treatment as usual. 
 
CBT group and mentoring sessions were conducted in campus-based clinic settings. Every effort 
was made to run CBT group meetings at times that maximized attendance; some students (n = 
30) could not participate due to scheduling conflicts (e.g., classes, jobs). On average, four to six 
students participated in the CBT group portion of ACCESS. Groups were conducted using a 
discussion-based format to encourage active participation, and participants received written 
handouts summarizing important session content. Guest speakers from various campus support 
units (e.g., disability services, student health) met briefly with the groups to describe and answer 
questions about their services. Mentoring sessions were generally conducted in person within a 
few days following the corresponding group session; occasionally, when in-person sessions were 
not feasible (e.g., illness), mentoring was instead conducted by phone. 
 
Graduate student research assistants and one master’s-level licensed professional counselor 
served as group leaders and mentors. Prior to being in the study, all received extensive training 
that included assigned readings, group discussions, observations, and role playing. Supervision 
was provided to group leaders and mentors throughout the study by licensed doctoral-level 
clinical psychologists. Treatment fidelity was further enhanced through use of a treatment 
manual containing detailed session-by-session outlines that guided group leaders and mentors in 
their delivery of ACCESS. All treatment sessions were audio recorded, and 20% of these were 
randomly selected and reviewed for treatment fidelity by the group and mentor supervisors. 
Overall adherence to the content of treatment sessions was excellent, with fidelity ratings of 96.4 
and 95.6% obtained for the group and mentoring sessions, respectively. 
 
All study procedures were approved annually by each university’s Institutional Review Board. In 
addition to receiving monetary compensation for completing measures, participants were given a 
written summary of their screening evaluation results, which could be used as documentation for 
receiving campus support and treatment (e.g., accommodations, medication). 
Table 2. Outcome Data and Model Fit Indices 
 Time 1 Time 2 Time 3 Model fit for multiple group models 
 M (SD) M (SD) M (SD)     
 n n n    RMSEA 
[90% CI] Outcome ACCESS DTC ACCESS DTC ACCESS DTC χ2 (df) CFI SRMR 
CAARS Total 34.48 (9.16) 34.73 (8.82) 29.64 (9.28) 31.54 (10.43) 28.46 (9.48) 31.68 (9.48) 9.31 (7) .99 .12 .05 [.00, .13] 
 117 130 111 109 95 102     
IN 19.93 (4.57) 20.36 (4.45) 16.25 (5.20) 18.22 (5.70) 15.05 (5.24) 17.86 (5.28) 16.22 (7) .94 .20 .10 [.04, .17] 
 117 130 111 109 95 102     
HI 14.55 (5.74) 14.37 (5.61) 13.39 (5.32) 13.32 (6.23) 13.41 (5.57) 13.81 (5.89) 3.87 (5) 1 .06 .00 [.00, .11] 
 117 130 111 109 95 102     
BRIEF GEC 157.17 (18.13) 155.62 (22.30) 145.86 (25.05) 154.00 (24.46) 140.39 (24.85) 150.01 (24.69) 9.09 (7) .98 .25 .05 [.00, .13] 
 118 131 113 111 93 100     
BRI 60.70 (11.22) 59.40 (11.05) 58.02 (12.28) 59.85 (11.95) 56.88 (11.86) 59.06 (11.95) 3.38 (7) 1 .10 .00 [.00, .06] 
 118 131 113 111 93 100     
MCI 95.62 (14.71) 95.87 (14.84) 87.58 (15.23) 94.15 (15.18) 83.51 (15.07) 90.93 (15.48) 7.05 (5) .96 .07 .06 [.00, .15] 
 118 131 113 111 93 100     
BDI-II 14.60 (10.55) 14.82 (10.57) 12.97 (9.98) 18.47 (11.97) 13.12 (11.39) 16.19 (11.62) 7.80 (7) .99 .08 .03 [.00, .12] 
 119 131 113 113 95 103     
BAI 13.67 (11.79) 12.15 (10.29) 14.32 (11.40) 14.65 (11.38) 12.27 (10.53) 14.29 (12.04) 8.28 (5) .98 .03 .07 [.00, .16] 
 119 131 113 113 94 102     
TOAK 20.86 (6.19) 20.85 (6.23) 29.93 (4.86) 22.70 (5.68) 29.03 (5.00) 23.15 (5.63) 17.91 (5) .93 .08 .14 [.08, .22] 
 119 129 113 110 94 103     
SFS 46.74 (10.97) 44.74 (11.00) 61.16 (11.64) 48.84 (12.09) 61.18 (12.27) 49.58 (13.58) 6.33 (5) .99 .09 .05 [.00, .14] 
 119 131 112 113 93 104     
ACS-CV 36.27 (7.88) 36.03 (8.23) 32.93 (7.84) 35.77 (7.91) 31.91 (8.13) 35.54 (8.71) 4.43 (5) 1 .07 .00 [.00, .12] 
 119 131 110 113 95 103     
Note. Outcome data reported in the original, unstandardized metric; CFI = comparative fit index; SRMR = standardized root mean square residual; RMSEA = 
root mean square error of approximation; ACCESS = immediate treatment; DTC = Delayed Treatment Control; CAARS total = Conners Adult ADHD Rating 
Scale total score; IN = CAARS inattention; HI = CAARS hyperactivity-impulsivity; BRIEF GEC = Behavioral Rating Inventory of Executive Functioning 
Global Executive Composite; BRI = BRIEF Behavior Regulation Index; MCI = BRIEF Metacognition Index; BDI-II = Beck Depression Inventory–II; BAI = 
Beck Anxiety Inventory; TOAK = Test of ADHD Knowledge; SFS = Strategies for Success; ACS-CV = ADHD Cognitions Scale–College Version.
Results 
 
Data Analytic Plan 
 
Latent growth curve models, which allow for analysis of cases with missing data, were estimated 
to evaluate how treatment condition (immediate vs. delayed) influenced change over time. The 
models were estimated in Mplus 8.1 using maximum likelihood estimation with robust standard 
errors, which incorporates a model-based method for estimating parameters despite missing data 
(Enders, 2010). Scores for the three time points (preactive, postactive, and postmaintenance) 
served as the indicators. Latent intercept and slope factors were specified and allowed to covary. 
For the intercept, the three factor loadings were set to 1. For the slope, the first indicator 
(preactive) was fixed to zero, the second indicator was freely estimated, and the final indicator 
(postmaintenance) was fixed to 1. In this specification, the intercept value reflects initial 
preactive status, and the slope value reflects total growth from preactive (Time 1, coded 0) to 
postmaintenance (Time 3, coded 1). 
 
A multiple-group framework was used to evaluate differential change over time. The immediate 
ACCESS and DTC conditions were specified as the two groups, and Wald tests of model 
constraints were used to test whether the slope means differed significantly between the two 
groups. Rarely were there significant effects of treatment condition on intercept values (i.e., 
pretreatment scores), consistent with random assignment to condition, and so these effects were 
omitted from the main text for clarity. Because the slopes were constrained to be equal, a 
significant model test indicates a rejection of the null hypothesis of equal slopes in the two group 
conditions. Within each group, the residual variances of the intercept and slope, as well as their 
residual covariance, were freely estimated. The residual variances of the slopes tended to be 
small, and in a handful of cases (e.g., BDI-II) they were fixed to 0 to facilitate convergence to 
proper solutions. The residual variances of the three indicators were constrained to be equal 
within each group to reflect homoscedasticity (Preacher et al., 2008). Initial growth analyses 
indicated that site differences had no impact on the trajectories for either group; thus, site was 
not included in the final growth models. Model fit for the multiple group models is displayed 
in Table 2, with the data reported in the original, unstandardized metric. Reported below for each 
outcome are effect sizes, expressed in the Cohen’s d metric, representing the magnitude of the 
difference in slopes between the ACCESS and DTC conditions (i.e., the effect of condition on 
change). For the purposes of interpretation, Cohen’s d values on the order of .20, .50, and .80 






The immediate ACCESS (b = −6.16, SE = .82, p < .001) and DTC (b = −2.90, SE = .66, p < 
.001) groups showed significant declines in overall ADHD symptomatology as measured by 
CAARS Total ADHD scores, with the decline being significantly greater in the ACCESS 
condition, Wald (1) = 9.78, p = .002, d = .39 [.15, .65]. The ACCESS (b = −4.83, SE = .52, p < 
.001) and DTC (b = −3.32, SE = .38, p < .001) groups also showed significant declines in 
inattention symptoms as measured by CAARS IN scores, with a significantly larger decline 
observed among ACCESS participants, Wald (1) = 16.08 p < .001, d = .50 [.25, .76]. As shown 
in Figure S1 (in the online supplemental materials), these reductions in ADHD symptoms were 
evident at the end of the active phase and remained stable throughout the maintenance phase of 
the intervention. In contrast with the marginal decline in hyperactive-impulsive symptoms 
(CAARS HI scores) shown by the DTC condition (b = −.64, SE = .34, p = .060), the ACCESS 
group showed a significant decline (b = −1.32, SE = .43, p = .002); the slopes, however, did not 




In terms of overall EF deficits as measured by BRIEF-A GEC scores, the DTC condition showed 
a marginal decline (b = −3.31, SE = 2.02, p = .101), whereas the immediate ACCESS group (b = 
−16.69, SE = 2.28, p < .001) showed a significant decline and its slope was significantly greater 
than that of the DTC condition, Wald (1) = 22.32, p < .001, d = .56 [.31, .81]. In contrast with the 
DTC group that displayed no change in behavioral regulation deficits as measured by BRIEF-A 
BRI scores (b = .14, SE = .85, p = .867), the ACCESS group (b = −4.17, SE = .98, p < .001) 
showed a significant decline and the slopes differed significantly between the conditions, Wald 
(1) = 10.78, p = .001, d = .43 [.17, .68]. Regarding metacognition deficits (BRIEF-A MCI 
scores), there were significant declines in both the ACCESS group (b = −11.26, SE = 1.82, p < 
.001) and the DTC condition (b = −3.14, SE = 1.59, p = .049), but the decline for ACCESS 
participants was significantly greater, Wald (1) = 18.25, p < .001, d = .43 [.18, .68]. For all three 
BRIEF-A measures, these improvements in EF were evident at the end of the active phase and 





Analyses of the BDI-II revealed no significant reductions in depression symptoms for either the 
ACCESS (b = −.77, SE = .74, p = .297) or DTC groups (b = 1.81, SE = 1.14, p = .111), and the 
slopes did not differ significantly, Wald (1) = 2.13, p = .145, d = .24 [−.01, .49]. Analyses of BAI 
scores indicated that there was a significant increase in anxiety for the DTC group (b = 
2.78, SE = .98, p = .005), but no change in the ACCESS condition (b = −1.10, SE = 1.16, p = 
.346); the slopes between groups differed significantly, Wald (1) = 6.22, p = .013, d = .33 [.08, 
.58]. Although emotional functioning did not improve, it is of clinical interest to note that 
depression and anxiety levels seemed to stabilize for ACCESS participants, while worsening for 
DTC participants (see Figure S3 in the online supplemental materials). 
Secondary Outcomes 
 
Clinical Change Mechanisms 
 
The immediate ACCESS (b = 8.29, SE = .53, p < .001) and DTC (b = 1.99, SE = .41, p < .001) 
groups showed significant growth in their knowledge of ADHD as measured by TOAK scores. 
This increase in ADHD knowledge was significantly greater among ACCESS participants, Wald 
(1) = 102.24, p < .001, d = 1.21 [.94, 1.48]. The immediate ACCESS (b = 14.50, SE = 1.33, p < 
.001) and DTC (b = 4.11, SE = .97, p < .001) groups also showed significant growth in their use 
of behavioral strategies as measured by SFS scores, with the increase being significantly larger 
in the ACCESS condition, Wald (1) = 42.24, p < .001, d = .81 [.56, 1.07]. Analyses of 
maladaptive thinking as measured by ACS-CV scores indicated that the DTC group did not 
significantly change over time (b = −.44, SE = .63, p = .487). The ACCESS condition did change 
significantly over time (b = −4.24, SE = .74, p < .001), and this decline in maladaptive thinking 
was significantly greater for the immediate ACCESS participants, Wald (1) = 15.57, p < 
.001, d = .50 [.25, .75]. As shown in Figure S4 (in the online supplemental materials), these 
improvements in clinical change mechanisms were evident at the end of the active phase and 




A descriptive summary of participants’ use of treatment and other support services appears 
in Table 3. Because these outcomes are categorical, scored 0 and 1, an alternate model 
specification was used. Growth curve models with categorical indicators do not afford the same 
markers of model fit and estimating a multiple-group model is much less straightforward for 
categorical outcomes. As before, latent intercept (1, 1, 1) and slope (0, *, 1) factors were 
estimated, and the residual variances and covariance for the intercept and slope were freely 
estimated. Treatment condition was included as an observed predictor (coded 0 = delayed, 1 = 
immediate). This model thus estimates the overall slope for the entire sample, along with how 
treatment status predicts variation in the slope. 
 
Table 3. Service Utilization by Group Over Time 
Service % Preactive % Postactive % Postmaintenance 
Disability services    
ACCESS 25.3 67.3 60.9 
DTC 22.1 37.5 38.0 
ADHD medication    
ACCESS 53.3 68.9 67.0 
DTC 41.7 59.4 71.9 
Other medication    
ACCESS 26.1 24.0 30.1 
DTC 29.1 32.4 37.6 
Counseling services    
ACCESS 33.7 25.3 34.5 
DTC 52.4 39.4 45.1 
Note. Disability services = use of formal disability accommodations approved by campus disability office; ACCESS 
= immediate treatment; DTC = Delayed Treatment Control; ADHD = attention deficit/hyperactivity disorder; 
ADHD medication = use of medication to treat ADHD; Other medication = use of medication to treat other mental 
health and medical conditions; Counseling services = use of counseling received outside of ACCESS program. 
 
The sample overall did not change in its use of disability service accommodations over time, b = 
.39, SE = .49, p = .415, but treatment status significantly moderated change, with the immediate 
ACCESS condition showing a significant increase in using disability services, b = 1.96, SE = 
.58, p = .001, d = 1.03 [.48, 1.59]. Although the sample overall increased its use of ADHD 
medication, b = 3.16, SE = 1.39, p = .022, treatment status did not significantly moderate this 
change, b = −.81, SE = 1.24, p = .513, d = .18 [−.32, .68]. There was no change in overall sample 
use of medications for other medical and mental health conditions, b = 1.36, SE = 12.00, p = 
.910, and treatment status did not significantly moderate the slope, b = −.58, SE = 1.75, p = 
.740, d = .25 [−1.02, 1.52]. Likewise, the sample overall did not change in its use of counseling 
services delivered outside of ACCESS, b = −.20, SE = .28, p = .468, and treatment status did not 
significantly moderate the slope, b = −.03, SE = .20, p = .900, d = .13 [−1.40, 1.66]. 
 
Clinical Significance of Findings 
 
To inform clinical practice, reliable change indices (RCI; Jacobson & Truax, 1992) were 
calculated to determine individual rates of response to treatment. Preactive to postmaintenance 
phase difference scores were used for these calculations, with positive differences reflecting 
desired therapeutic change for all outcome measures. Consistent with the Jacobson and Truax 
(1992) guidelines, RCIs greater than 1.96 represented evidence of statistically significant 
improvement. Although positive RCIs ≤1.96 can reflect improvement, these changes are not of a 
magnitude to be considered statistically significant and therefore are likely due to chance. 
Because individuals with ADHD are at increased risk for displaying deterioration in their 
functioning (Barkley, 2015), a third clinical significance category was generated, operationally 
defined as RCIs <0, to examine outcomes reflecting a worsening in functioning over time. 
 
Table 4. Treatment Response Classifications Based on Reliable Change Indices 
Outcome % Worse % Improved 
% Reliable 
improvement χ2 
CAARS IN     
ACCESS 12.9 25.8 61.3 17.55*** 
DTC 22.5 46.1 31.4  
BRIEF-A GEC     
ACCESS 22.6 26.9 50.5 9.89** 
DTC 40.0 30.0 30.0  
BDI-II Total     
ACCESS 37.9 41.1 21.1 6.22* 
DTC 54.4 26.2 19.4  
BAI Total     
ACCESS 42.6 46.8 10.6 6.93* 
DTC 52.0 46.1 2.0  
TOAK Total     
ACCESS 5.3 51.1 43.6 35.89*** 
DTC 22.5 68.6 8.8  
SFS Total     
ACCESS 9.7 58.1 31.2 18.45*** 
DTC 27.6 62.2 10.2  
ACS-CV Total     
ACCESS 23.2 65.3 11.6 8.07* 
DTC 41.7 51.5 6.8  
Note. CAARS IN = Conners Adult ADHD Rating Scale Inattention; DTC = Delayed Treatment Control; BRIEF-A 
GEC = Behavioral Rating Inventory of Executive Functioning–Adults Global Executive Composite; BDI-II = Beck 
Depression Inventory; BAI = Beck Anxiety Inventory; TOAK = Test of ADHD Knowledge; SFS = Strategies for 
Success; ACS-CV = ADHD Cognitions Scale–College Version. 
* p < .05. ** p < .01. *** p < .001. 
 
Higher rates of reliable improvement among immediate ACCESS participants were revealed by 
χ2 analyses of the observed RCI distributions (see Table 4), in terms of inattention (61.3 vs. 
31.4%), EF (50.5 vs. 30.0%), anxiety (10.6 vs. 2.0%), knowledge of ADHD (43.6 vs. 8.8%), and 
use of behavioral strategies (31.2 vs. 10.2%). Although rates of reliable improvement were 
essentially equivalent for immediate ACCESS and DTC participants with respect to depression 
and maladaptive thinking patterns, higher percentages of DTC participants displayed a 
worsening in their reports of both depression (54.4 vs. 37.9%) and maladaptive thinking (41.7 vs. 
23.2%). Further evidence of this increased risk for a deterioration in functioning among DTC 
versus immediate ACCESS participants was also seen among the distributions for inattention 
(22.5 vs. 12.9%), EF (40.0 vs. 22.6%), anxiety (52.0 vs. 42.6%), knowledge of ADHD (22.5 vs. 




Findings from this large-scale multisite RCT revealed numerous improvements in functioning 
among the college students with ADHD who received ACCESS on an immediate versus delayed 
basis. In terms of primary outcomes, immediate ACCESS participants displayed statistically 
significant greater declines in their overall ADHD symptomatology, which was driven largely by 
a decline in their self-reported inattention symptoms. Effect sizes associated with these 
differences were medium in strength (Cohen’s d ranging from .39 to .50). Immediate ACCESS 
participants also displayed statistically significant improvements in executive functioning (EF), 
with medium effect sizes noted for overall EF deficits (d = .56), as well as for EF deficits 
pertaining specifically to behavioral regulation (d = .43) and metacognition (d = .43) skills. 
Contrary to study expectations, neither group exhibited a statistically significant decline in 
overall levels of depression. Although immediate ACCESS participants did not show a 
significant decline in overall levels of anxiety, there was a significant increase in anxiety for the 
DTC group. The slopes between the two groups were significantly different, thus suggesting a 
significant worsening of anxiety symptoms among DTC participants. 
 
Examination of hypothesized mechanisms of clinical change and participant service utilization 
also revealed statistically significant differences between the groups. Although both groups 
showed increases over time in their knowledge of ADHD and use of behavioral strategies, these 
increases were significantly greater for participants in the immediate ACCESS group versus the 
DTC condition. Effect sizes associated with these group differences were large, with 
Cohen’s d estimates of 1.21 and .81 for ADHD knowledge and behavioral strategies, 
respectively. The immediate ACCESS group also displayed a significantly greater decline in 
maladaptive thinking than the DTC condition, with the difference between the groups being of 
moderate effect size (d = .50). Such improvements in ADHD knowledge, use of behavioral 
strategies, and adaptive thinking skills, as measured by our study-specific measures, speak to 
their potential role as clinical change mechanisms, lending support to the construct validity of 
our design. In terms of service utilization, group status moderated use of disability services, with 
immediate ACCESS participants displaying a significant increase in their use of disability 
accommodations. Both groups exhibited significantly increased use of ADHD medications over 
time, but this increase was not moderated by group status. The fact that both groups increased 
their use of ADHD medication may have been facilitated by participants’ receipt of written 
screening evaluation summaries that could be used as documentation for receiving such services. 
Neither group, however, displayed statistically significant increases in their use of medication for 
other mental health conditions or in their participation in counseling outside of ACCESS. 
 
Our clinical significance analyses, which address therapeutic change at the level of individuals 
rather than group aggregates, also revealed findings in line with study expectations. Relative to 
DTC participants, higher percentages of immediate ACCESS participants displayed reliable 
improvements in multiple domains of functioning, including self-reported inattention symptoms, 
executive functioning, anxiety symptoms, knowledge of ADHD, and use of behavioral strategies. 
Of additional clinical significance are findings at the other end of the continuum. Specifically, 
higher percentages of DTC participants displayed a worsening in their functioning relative to 
immediate ACCESS participants in terms of inattention, executive functioning, depression, 
anxiety, knowledge of ADHD, behavioral strategy use, and maladaptive thinking. Such evidence 
of a deterioration in functioning is not completely unexpected, given what is known about the 
deleterious impact of ADHD across the life span (Barkley, 2015). What is surprising, and at the 
same time sobering, is the magnitude of the worsening and the fact that it occurred within a 
relatively short 12-month time frame among DTC participants who could and did receive 
treatments other than ACCESS (e.g., ADHD medication). 
 
Although it is clinically meaningful that ACCESS participants were less likely to experience a 
worsening in their depression and anxiety symptoms according to the RCI results, their failure to 
improve in these domains was somewhat surprising. This lack of improvement could be due to 
the timing of when the adaptive thinking portion of ACCESS directly addresses emotional 
functioning. Because this occurs in Week 5 of the 8-week active phase (see Figure 1), ACCESS 
participants may not have had enough time to master the adaptive thinking skills necessary for 
bringing about improvements in depression and anxiety. Assuming this to be the case, one option 
for addressing this would be to identify participants with elevated pretreatment levels of 
depression/anxiety and to have mentors begin targeting these emotional features at an earlier 
stage of ACCESS. Mentors could also encourage depressed/anxious participants to seek out and 
concurrently receive more intensive individual CBT counseling outside of ACCESS. Such 
recommendations are in keeping with the notion that ADHD is best managed via multimodal 
interventions (Barkley, 2015). In this regard, ACCESS is well suited to being used in 
combination with other treatments (e.g., medication, accommodations, counseling) to address the 
multiple psychosocial needs of emerging adults with ADHD attending college. 
 
Despite the encouraging nature of the obtained findings, it remains necessary to acknowledge 
limitations that have bearing on conclusions drawn from this RCT. For example, the primary and 
secondary outcome measures reported in this article were somewhat limited in scope and based 
exclusively on self-report. As noted earlier, our RCT did include measures examining other 
outcomes (e.g., academic, general daily functioning) but space limitations precluded their 
inclusion in the current article. These will be addressed subsequently, including analyses of more 
objective measures of academic functioning drawn from educational records (see Appendix). 
Two additional issues not addressed in this article are: (a) the temporal stability of treatment-
induced improvements following termination from ACCESS, and (b) the potential moderating 
effects of sex/gender, race/ethnicity, and variables of clinical interest (e.g., comorbid features) on 
response to treatment. Both issues will be thoroughly examined in a subsequent article focused 
on the treatment response of immediate ACCESS participants, for whom outcome data are 
available not only from the active and maintenance phases, but also from a follow-up assessment 
(see Figure 2) conducted 6 months after participation in ACCESS had been completed. The fact 
that immediate and delayed treatment participants could receive other forms of treatment while 
participating in the study makes it difficult to ascertain the unique contribution that ACCESS 
made to observed improvements in outcome. Evidence indirectly suggesting that ACCESS did 
indeed contribute to treatment gains may be inferred from the absence of group differences in 
their use of other treatments (i.e., ADHD medication, medication for other mental health 
conditions, counseling services). Another potential limitation affecting the external validity of 
these findings is the gender distribution of our sample (66% female), which differs from the 
relatively higher proportion of males known to have ADHD in the general population. The 
reasons for this discrepancy are not entirely clear, but it is first important to note that the gender 
distribution of our sample is in line with the 60–67% representation of female undergraduates at 
our two sites. Also speaking to this issue is the fact that longitudinal research has shown that 
females with ADHD generally attain more years of formal education than do males with this 
same condition (Barkley et al., 2008). 
 
Bearing these limitations in mind, findings from this large multisite RCT study build upon those 
reported from our earlier open clinical trial (Anastopoulos & King, 2015; Anastopoulos et al., 
2018) and provide strong evidence in support of the efficacy of ACCESS as a treatment for 
emerging adults with ADHD attending college. Although ACCESS shares features found in 
other psychosocial treatments for college students with ADHD (e.g., CBT, OTMP, coaching), it 
uniquely blends many of these components together into a single treatment package that is 
further enhanced by the inclusion of novel treatment elements, such as: an intensive ADHD 
knowledge component to give college students a developmentally appropriate understanding of 
their own ADHD; simultaneous delivery of group treatment and individual mentoring to 
facilitate acquisition and mastery of new knowledge and skills; and a longer duration of 
treatment (i.e., active and maintenance phases delivered across two semesters) to better address 
the chronic nature of ADHD. Given the clinically challenging nature of the college students in 
the study and the rigor with which ADHD and comorbid conditions were identified in our 
multisite sample, it is likely that ACCESS is well-suited to addressing the needs of other students 
with ADHD in postsecondary settings. Its feasibility as a treatment option stems in part from a 
consideration of the fact that participation in ACCESS was quite high during the active treatment 
phase: 83.2% attended at least six of eight planned group sessions; 85.7% attended a comparable 
number of mentoring sessions. Also speaking to its feasibility is that ACCESS was implemented 
in two different university settings with the strong support of campus support staff. Thus, our 
findings represent an important first step in closing the gap from research to practice. Left to 
future research is the task of determining how effectively ACCESS can be disseminated in other 
college settings, especially those in which resources (e.g., disability services) and staffing (e.g., 
level of ADHD expertise) may differ from those of the two sites in the current study, thereby 
potentially requiring minor changes in staff training and program implementation. 
 
In conclusion, college students with ADHD are at increased risk for a multitude of educational 
and psychosocial difficulties that have serious personal, institutional, and public health 
implications, not only during college, but also during the transition into a postcollege world 
where demands for self-regulation are greater. To reduce this risk, it is important for college 
students with ADHD to have ready access to evidence-based treatment. Building on the results 
of our open clinical trial, findings from the current RCT suggest that ACCESS is a promising 
new evidence-based treatment that can play an important role in the overall clinical management 




Additional information about ACCESS, including information about the treatment manual and 
study-specific measures, can be found at: https://accessproject.uncg.edu/. The authors wish to 
disclose the following potential conflicts of interest. Arthur D. Anastopoulos, Joshua M. 
Langberg, and Laura D. Eddy are authors on a forthcoming publication entitled, CBT for College 
Students with ADHD—A Clinical Guide to ACCESS. Arthur D. Anastopoulos is also a co-author 
of the ADHD Rating Scale–5, a modified version of which was used in this study. The research 
reported here was supported by the Institute of Education Sciences, U.S. Department of 
Education, through Grant R305A150207 awarded to the University of North Carolina 
Greensboro. The opinions expressed are those of the authors and do not represent views of the 
Institute or the U.S. Department of Education. We thank the disability, student health, and 
counseling service staffs at both universities for their partnership in referring college students to 
the study and for providing presentations about their services to study participants. We would 
also like to extend a special thank you to Kevin R. Murphy for his invaluable contributions to the 




American Psychiatric Association. (2013). Diagnostic and statistical manual of mental 
disorders (5th ed.). 
Anastopoulos, A. D., DuPaul, G. J., Weyandt, L. L., Morrissey-Kane, E., Sommer, J. L., Rhoads, 
L. H., Murphy, K. R., Gormley, M. J., & Gudmundsdottir, B. G. (2018). Rates and 
patterns of comorbidity among first-year college students with ADHD. Journal of 
Clinical Child and Adolescent Psychology, 47(2), 236–247. 
10.1080/15374416.2015.1105137 
Anastopoulos, A. D., & King, K. A. (2015). A cognitive-behavior therapy and mentoring 
program for college students with ADHD. Cognitive and Behavioral Practice, 22(2), 
141–151. 10.1016/j.cbpra.2014.01.002 
Anastopoulos, A. D., King, K. A., Besecker, L. H., O’Rourke, S. R., Bray, A. C., & Supple, A. J. 
(2020). Cognitive-behavior therapy for college students with ADHD: Temporal stability 
of improvements in functioning following active treatment. Journal of Attention 
Disorders, 24(6), 863–874. 10.1177/1087054717749932 
Antshel, K. M., Hier, B. O., & Barkley, R. A. (2014). Executive functioning theory and ADHD. 
In S. Goldstein & J. A. Naglieri (Eds.), Handbook of executive functioning (pp. 107–120). 
Springer. 10.1007/978-1-4614-8106-5_7 
Arnett, J. J. (2007). Emerging adulthood: What is it, and what is it good for? Child Development 
Perspectives, 1(2), 68–73. 10.1111/j.1750-8606.2007.00016.x 
Barkley, R. A. (2015). Attention-deficit hyperactivity disorder: A handbook for diagnosis and 
treatment (4th ed.). Guilford Press. 
Barkley, R. A., Murphy, K. R., & Fischer, M. (2008). ADHD in adults: What the science says. 
Guilford Press. 
Beck, A. T., & Steer, R. A. (1993). Beck Anxiety Inventory manual. Psychological Corporation. 
Beck, A., Steer, R., & Brown, G. (1996). BDI-II, Beck Depression Inventory: Manual (2nd ed.). 
Psychological Corporation. 
Blasé, S. L., Gilbert, A. N., Anastopoulos, A. D., Costello, E. J., Hoyle, R. H., Swartzwelder, H. 
S., & Rabiner, D. L. (2009). Self-reported ADHD and adjustment in college: Cross-
sectional and longitudinal findings. Journal of Attention Disorders, 13(3), 297–309. 
10.1177/1087054709334446 
Conners, C. K., Erhardt, D., & Sparrow, E. (2006). Conners’ Adult ADHD Rating Scales. Multi-
Health Systems. 
DuPaul, G. J., Franklin, M. K., Pollack, B. L., Stack, K. S., Jaffe, A. R., Gormley, M. J., 
Anastopoulos, A. D., & Weyandt, L. L. (2018). Predictors and trajectories of educational 
functioning in college students with and without ADHD. Journal of Postsecondary 
Education and Disability, 31(2), 161–178. 
DuPaul, G. J., Power, T. J., Anastopoulos, A. D., & Reid, R. (2016). ADHD Rating Scale-5 for 
children and adolescents: Checklists, norms, and clinical interpretation. Guilford Press. 
DuPaul, G. J., Weyandt, L. L., Rossi, J. S., Vilardo, B. A., O’Dell, S., Carson, K. M., Verdi, G., 
& Swentosky, A. (2012). Double-blind, placebo-controlled, crossover study of the 
efficacy and safety of lisdexamfetamine dimesylate in college students with 
ADHD. Journal of Attention Disorders, 16(3), 202–220. 10.1177/1087054711427299 
Eagan, K., Stolzenberg, E. B., Ramirez, J. J., Aragon, M. C., Suchard, M. R., & Hurtado, S. 
(2014). The American freshman: National norms fall 2014. Higher Education Research 
Institute, UCLA. 
Enders, C. K. (2010). Applied missing data analysis. Guilford Press. 
First, M. B., Williams, J. B. W., Karg, R. S., & Spitzer, R. L. (2015). Structured clinical 
interview for DSM–5–Research version (SCID-5-RV). American Psychiatric Association. 
Fleming, A. P., & McMahon, R. J. (2012). Developmental context and treatment principles for 
ADHD among college students. Clinical Child and Family Psychology Review, 15, 303–
329. 10.1007/s10567-012-0121-z 
Fleming, A. P., McMahon, R. J., Moran, L. R., Peterson, A. P., & Dreessen, A. (2015). Pilot 
randomized controlled trial of dialectical behavior therapy group skills training for 
ADHD among college students. Journal of Attention Disorders, 19(3), 260–271. 
10.1177/1087054714535951 
Gormley, M. J., DuPaul, G. J., Weyandt, L. L., & Anastopoulos, A. D. (2019). First-year GPA 
and academic service use among college students with and without ADHD. Journal of 
Attention Disorders, 23(14), 1766–1779. 10.1177/1087054715623046 
Gu, Y., Xu, G., & Zhu, Y. (2018). A randomized controlled trial of mindfulness-based cognitive 
therapy for college students with ADHD. Journal of Attention Disorders, 22(4), 388–399. 
10.1177/1087054716686183 
He, J., & Antshel, K. (2017). Cognitive behavioral therapy for attention deficit/hyperactivity 
disorder (ADHD) in college students: A review of the literature. Cognitive and 
Behavioral Practice, 24(2), 152–173. 10.1016/j.cbpra.2016.03.010 
Hechtman, L. (2017). Attention deficit hyperactivity disorder: Adult outcome and its predictors. 
Oxford University Press. 
Jacobson, N. S., & Truax, P. (1992). Clinical significance: A statistical approach to defining 
meaningful change in psychotherapy research. In A. E. Kazdin (Ed.), Methodological 
issues & strategies in clinical research (pp. 631–648). American Psychological 
Association. 10.1037/10109-042 
Knouse, L. E., Mitchell, J. T., Kimbrel, N. A., & Anastopoulos, A. D. (2019). Development and 
evaluation of the ADHD Cognitions Scale for adults. Journal of Attention 
Disorders, 23(10), 1090–1100. 10.1177/1087054717707580 
LaCount, P. A., Hartung, C. M., Shelton, C. R., Clapp, J. D., & Clapp, T. K. (2015). Preliminary 
evaluation of a combined group and individual treatment for college students with 
attention-deficit/hyperactivity disorder. Cognitive and Behavioral Practice, 22(2), 152–
160. 10.1016/j.cbpra.2014.07.004 
LaCount, P. A., Hartung, C. M., Shelton, C. R., & Stevens, A. E. (2018). Efficacy of an 
organizational skills intervention for college students with ADHD symptomatology and 
academic difficulties. Journal of Attention Disorders, 22(4), 356–367. 
10.1177/1087054715594423 
Lewandowski, L., Gathje, R. A., Lovett, B. J., & Gordon, M. (2013). Test-taking skills in college 
students with and without ADHD. Journal of Psychoeducational Assessment, 31(1), 41–
52. 10.1177/0734282912446304 
Meaux, J. B., Green, A., & Broussard, L. (2009). ADHD in the college student: A block in the 
road. Journal of Psychiatric and Mental Health Nursing, 16(3), 248–256. 
10.1111/j.1365-2850.2008.01349.x 
Miller, L. A., Lewandowski, L. J., & Antshel, K. M. (2015). Effects of extended time for college 
students with and without ADHD. Journal of Attention Disorders, 19(8), 678–686. 
10.1177/1087054713483308 
Pinho, T. D., Manz, P. H., DuPaul, G. J., Anastopoulos, A. D., & Weyandt, L. L. (2019). 
Predictors and moderators of quality of life among college students with ADHD. Journal 
of Attention Disorders, 23(14), 1736–1745. 10.1177/1087054717734645 
Preacher, K. J., Wichman, A. L., MacCallum, R. C., & Briggs, N. E. (2008). Latent growth curve 
modeling. SAGE. 10.4135/9781412984737 
Prevatt, F., & Yelland, S. (2015). An empirical evaluation of ADHD coaching in college 
students. Journal of Attention Disorders, 19(8), 666–677. 10.1177/1087054713480036 
Rabiner, D. L., Anastopoulos, A. D., Costello, E. J., Hoyle, R. H., McCabe, S. E., & 
Swartzwelder, H. S. (2009). Misuse and diversion of prescribed ADHD medications by 
college students. Journal of Attention Disorders, 13(2), 144–153. 
10.1177/1087054708320414 
Ramsay, J. R. (2015). Psychological assessment of adults with ADHD. In R. A. Barkley 
(Ed.), Attention-deficit hyperactivity disorder: A handbook for diagnosis and 
treatment (pp. 475–500). Guilford Press. 
Roth, R. M., Isquith, P. K., & Gioia, G. A. (2005). Behavior rating inventory of executive 
function–Adult version. Psychological Assessment Resources. 
Safren, S., Perlman, C., Sprich, S., & Otto, M. W. (2005). Mastering your adult ADHD: A 
cognitive behavioral treatment program therapist guide. Oxford University Press. 
Scheithauer, M. C., & Kelley, M. L. (2017). Self-monitoring by college students with ADHD: 
The impact on academic performance. Journal of Attention Disorders, 21(12), 1030–
1039. 10.1177/1087054714553050 
Solanto, M. V. (2011). Cognitive-behavioral therapy for adult ADHD: Targeting executive 
dysfunction. Guilford Press. 
Van der Oord, S., Boyer, B. E., Van Dyck, L., Mackay, K. J., De Meyer, H., & Baeyens, D. 
(2020). A randomized controlled study of a cognitive behavioral planning intervention 
for college students with ADHD: An effectiveness study in student counseling services in 
Flanders. Journal of Attention Disorders, 24(6), 849–862. 10.1177/1087054718787033 
Weyandt, L. L., & DuPaul, G. J. (2012). College students with ADHD: Current issues and future 
directions. Springer. 
Wolf, L. E., Simkowitz, P., & Carlson, H. (2009). College students with attention-




The data reported in this article have not been previously published but were collected as part of 
a larger data collection effort (at one or more points in time). Additional findings from this larger 
data set have been reported in a second article currently under editorial review. Both articles 
examine the efficacy of the ACCESS intervention but address conceptually different outcomes. 
The current article addresses treatment-induced changes in primary ADHD symptoms, 
associated executive functioning and emotional features (i.e., depression, anxiety), clinical 
change mechanisms, and service utilization. The second article focuses exclusively on functional 
outcomes, in terms of treatment-induced changes in both educational functioning (i.e., grade 
point average, number of semester credits attempted, self-reported learning and study strategies) 
and daily functioning (i.e., general well-being, daily functioning and performance, relationships 
and communication). 
